CD19 and glioblastoma: It is noteworthy that the GB-749 glioblastoma hybrid tumor showed retention of glioma-related genes (PLAGL2, GFAP), whereas the lymphoma-derived hybrid tumor retained several B-cell antigen receptor (BCR)-related genes (CD19, CD20, CD71, CD79b).